Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1861-1861
Open Access | Times Cited: 19

Showing 19 citing articles:

Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development
Julie Ostrowsky, Leah C. Katzelnick, Nigel Bourne, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 2
Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis
Kusum Kharga, Lokender Kumar, Sanjay K. S. Patel
Biomedicines (2023) Vol. 11, Iss. 3, pp. 765-765
Open Access | Times Cited: 24
Emerging trends and therapeutic applications of monoclonal antibodies
M. Janaki Ramaiah, Hari P. Nalluri, Prakash Narayana Reddy, et al.
Gene (2024) Vol. 925, pp. 148607-148607
Closed Access | Times Cited: 5
Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis
Matteo Riccò, Antonio Cascio, Claudio Costantino, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 81-81
Open Access
Antimicrobial Potential of Cannabinoids: A Scoping Review of the Past 5 Years
Maria João Coelho, Maria Araújo, Márcia Carvalho, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 325-325
Open Access
Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus
Shuo Wang, Ziling Zhu, Jianmin Li
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1342-1352
Closed Access | Times Cited: 3
Nucleic Acids-Based Biomarkers for Alzheimer’s Disease Diagnosis and Novel Molecules to Treat the Disease
Giulia Bivona, Selene Sammataro, Giulio Ghersi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7893-7893
Open Access | Times Cited: 3
Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with “Spanish Flu”?
Florigio Lista, Mario Stefano Peragallo, Roberto Biselli, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 868-868
Open Access | Times Cited: 8
Antibody complementarity-determining region design using AlphaFold2 and DDG predictor
Takafumi Ueki, Masahito Ohue
The Journal of Supercomputing (2024) Vol. 80, Iss. 9, pp. 11989-12002
Open Access | Times Cited: 2
Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody against RSV, Bronchiolitis Virus): Mixed Results, Identification of Biases and Possible Role and Mechanisms of ADE (Antibod
Hélène Banoun
(2024)
Open Access | Times Cited: 1
Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention
Hélène Banoun
(2024)
Open Access | Times Cited: 1
A Protein Microarray-Based Respiratory Viral Antigen Testing Platform for COVID-19 Surveillance
Sungjun Beck, Rie Nakajima, Algis Jasinskas, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2238-2238
Open Access | Times Cited: 8
Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants
Nicola Principi, Giovanni Autore, Serafina Perrone, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 747-762
Closed Access | Times Cited: 3
The effect of polyclonal and monoclonal based antibodies as promising potential therapy for treatment of sepsis: A systematic review
Marzie Mahdizade Ari, Mohammad Esmaeil Amini, Mohammad Sholeh, et al.
New Microbes and New Infections (2024) Vol. 60-61, pp. 101435-101435
Open Access
Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody Against RSV Bronchiolitis Virus): Mixed Results, Identification of Biases, and Possible Role and Mechanisms of ADE (Antibody Dependent Enhancement)
Hélène Banoun
(2024)
Open Access
Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention
Hélène Banoun
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10369-10395
Open Access
Ultra-rapid detection of nuclear protein of severe fever with thrombocytopenia syndrome virus by colloidal gold immunochromatography assay
Zhiwei Huang, Jianhua Li, Wentao Wei, et al.
PeerJ (2024) Vol. 12, pp. e18275-e18275
Open Access
Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections
Catherine Weil-Olivier, David Salisbury, José-Antonio Navarro-Alonso, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access
Analysis of General Toxicity of Ergoferon
Е. А. Danchenko, I. А. Ertuzun, Л. И. Бугаева, et al.
Bulletin of Experimental Biology and Medicine (2023) Vol. 175, Iss. 5, pp. 644-648
Closed Access
Page 1

Scroll to top